Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10215647rdf:typepubmed:Citationlld:pubmed
pubmed-article:10215647lifeskim:mentionsumls-concept:C0014653lld:lifeskim
pubmed-article:10215647lifeskim:mentionsumls-concept:C0019010lld:lifeskim
pubmed-article:10215647lifeskim:mentionsumls-concept:C0013725lld:lifeskim
pubmed-article:10215647lifeskim:mentionsumls-concept:C0037473lld:lifeskim
pubmed-article:10215647lifeskim:mentionsumls-concept:C0387583lld:lifeskim
pubmed-article:10215647lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:10215647lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:10215647lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:10215647lifeskim:mentionsumls-concept:C1980011lld:lifeskim
pubmed-article:10215647lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:10215647pubmed:issue2lld:pubmed
pubmed-article:10215647pubmed:dateCreated1999-5-20lld:pubmed
pubmed-article:10215647pubmed:abstractTextConventional nonsteroidal anti-inflammatory drugs inhibit both cyclooxygenase (Cox) isoforms (Cox-1 and Cox-2) and may be associated with nephrotoxicity. The present study was undertaken to assess the renal effects of the specific Cox-2 inhibitor, MK-966. Healthy older adults (n = 36) were admitted to a clinical research unit, placed on a fixed sodium intake, and randomized under double-blind conditions to receive the specific Cox-2 inhibitor, MK-966 (50 mg every day), a nonspecific Cox-1/Cox-2 inhibitor, indomethacin (50 mg t.i.d.), or placebo for 2 weeks. All treatments were well tolerated. Both active regimens were associated with a transient but significant decline in urinary sodium excretion during the first 72 h of treatment. Blood pressure and body weight did not change significantly in any group. The glomerular filtration rate (GFR) was decreased by indomethacin but was not changed significantly by MK-966 treatment. Thromboxane biosynthesis by platelets was inhibited by indomethacin only. The urinary excretion of the prostacyclin metabolite 2,3-dinor-6-keto prostaglandin F1alpha was decreased by both MK-966 and indomethacin and was unchanged by placebo. Cox-2 may play a role in the systemic biosynthesis of prostacyclin in healthy humans. Selective inhibition of Cox-2 by MK-966 caused a clinically insignificant and transient retention of sodium, but no depression of GFR. Inhibition of both Cox isoforms by indomethacin caused transient sodium retention and a decline in GFR. Our data suggest that acute sodium retention by nonsteroidal anti-inflammatory drugs in healthy elderly subjects is mediated by the inhibition of Cox-2, whereas depression of GFR is due to inhibition of Cox-1.lld:pubmed
pubmed-article:10215647pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:languageenglld:pubmed
pubmed-article:10215647pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:citationSubsetIMlld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10215647pubmed:statusMEDLINElld:pubmed
pubmed-article:10215647pubmed:monthMaylld:pubmed
pubmed-article:10215647pubmed:issn0022-3565lld:pubmed
pubmed-article:10215647pubmed:authorpubmed-author:LasseterK CKClld:pubmed
pubmed-article:10215647pubmed:authorpubmed-author:FitzGeraldG...lld:pubmed
pubmed-article:10215647pubmed:authorpubmed-author:KapoorSSlld:pubmed
pubmed-article:10215647pubmed:authorpubmed-author:GertzB JBJlld:pubmed
pubmed-article:10215647pubmed:authorpubmed-author:QuanHHlld:pubmed
pubmed-article:10215647pubmed:authorpubmed-author:MorrisonB WBWlld:pubmed
pubmed-article:10215647pubmed:authorpubmed-author:AntesLLlld:pubmed
pubmed-article:10215647pubmed:authorpubmed-author:McAdamBBlld:pubmed
pubmed-article:10215647pubmed:authorpubmed-author:Catella-Lawso...lld:pubmed
pubmed-article:10215647pubmed:authorpubmed-author:KujubuDDlld:pubmed
pubmed-article:10215647pubmed:issnTypePrintlld:pubmed
pubmed-article:10215647pubmed:volume289lld:pubmed
pubmed-article:10215647pubmed:ownerNLMlld:pubmed
pubmed-article:10215647pubmed:authorsCompleteYlld:pubmed
pubmed-article:10215647pubmed:pagination735-41lld:pubmed
pubmed-article:10215647pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:meshHeadingpubmed-meshheading:10215647...lld:pubmed
pubmed-article:10215647pubmed:year1999lld:pubmed
pubmed-article:10215647pubmed:articleTitleEffects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.lld:pubmed
pubmed-article:10215647pubmed:affiliationUniversity of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania, USA. francesca@spirit.GCRC.upenn.edulld:pubmed
pubmed-article:10215647pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10215647pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10215647pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:10215647pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:10215647pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10215647lld:pubmed
More...